CD8A and neoplasm: showed that ART1 expression was associated with reduced tumour infiltration of P2X7+ CD8 T cells in non-small cell lung cancer (NSCLC) patients, while in murine immune competent lung tumour models, ART1 knockdown decreased tumour growth (55).